Arjun Kampani

SVP & General Counsel Arjun Kampani sells 88,000 shares of RKLB at $107.98; stock down 15.8% in 30 days and 29.0% from 52-week high

Arjun Kampani, SVP & General Counsel of Rocket Lab, sold 88.0K shares at $107.98 for $9,502,240.00 on 2026-06-18, reducing his holdings by 25.0% from 352.7K to 264.7K shares. The sale occurs as RKLB stock has declined 15.8% over the prior 30 days and sits 29.0% below its 52-week high of $151.00. Across his cross-ticker open-market history, Kampani's prior 20 sells averaged -5.8% return in 30 days and +71.4% in 90 days, with a well-timed sell rate of 0.00% — indicating his past sales have consistently been followed by stock appreciation rather than declines. At RKLB specifically, all 5 of his prior trades (conducted on 2026-05-28) remain outcomes-unmeasurable. The company is unprofitable (full-year net income was negative) despite strong revenue growth of +38.0% annually and $200.3M in latest quarterly revenue. The transaction is sized materially but falls within the expected variance of a large shareholder's periodic portfolio activity.

SVP & General Counsel sold 23,804 shares at blended avg $147.43 on 2026-05-28 (scheduled 10b5-1 plan), stock now -19.0% from 52-week high

Arjun Kampani executed 8 separate sales totaling 23,804 shares for $3,509,510.74 on 2026-05-28 at prices ranging from $143.15 to $150.26, reducing his holdings by 6.3%. This transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-19, meaning the sales were scheduled rather than discretionary timing decisions. The stock has since declined to $122.39, trading 19.0% below its 52-week high of $151.00. Notably, his prior trades at RKLB (5 sales in March 2026) showed negative 30-day returns (ranging from -4.0% to -8.6%) followed by substantial 90-day gains (102.8% to 113.0%), a pattern that does not appear in his cross-ticker track record where the average 90-day return after 20 prior sells was +72.2%. The company is currently unprofitable with net income of $-45,022,000.00 against revenue of $200,348,000.00, though it achieved annual revenue growth of +38.0%.

SVP & General Counsel Arjun Kampani sold 98,668 shares for $14.2M on 2026-05-26/27 per 10b5-1 plan.

Arjun Kampani executed 8 separate sales totaling 98,668 shares (98.7K shares) for $14,246,080.47 ($14.2M) on 2026-05-26 and 2026-05-27 under a pre-arranged 10b5-1 trading plan. Transaction prices ranged from $139.41 to $150.00, with a blended average of $144.38, compared to a current price of $148.03. The sales reduced his holdings by 20.8% (from 475.2K to 376.5K shares). Because this transaction is part of a scheduled 10b5-1 plan rather than discretionary action, the timing reflects a pre-established schedule rather than an active investment decision. His prior 5 trades at this ticker (all on 2026-03-04) showed negative 30-day returns ranging from -4.0% to -8.6%, though all posted positive 90-day returns (+102.8% to +113.0%). The company is currently unprofitable (net income $-45.0M most recent quarter) despite strong revenue growth of +38.0% year-over-year and a substantial market cap of $85.7B.

SVP & General Counsel sells 52,472 shares for $3,707,381.05; reduces stake to 398.0K shares amid stock near 90d recovery.

Kampani Arjun executed 10 separate sales totaling 52,472 shares for $3,707,381.05 across March 2–4, 2026, reducing holdings by 11.6% from 450,460 shares to 397,988 shares post-transaction. The blended average price of $70.65 sits near current price of $71.91, reflecting trades executed during a period when the stock has risen 45.7% over the prior 90 days from deeper levels ($16.37–$96.30 52-week range) and currently trades 25.3% below its 52-week high. Arjun's prior trades at RKLB—five sales between September and November 2025—yielded strong subsequent gains (30-day returns ranging +38.2% to +92.8%; 90-day returns +15.7% to +77.0%), but none of those 5 sales were well-timed on the 90-day measure, meaning the stock rose after each sale. His cross-ticker track record shows a 9.09% well-timed rate across 11 prior sells. Against this backdrop of strong recent momentum and a company with $155.1M quarterly revenue but negative annual net income of $-18.3M, the scale of this sale—liquidating over one-tenth of his holdings—does not map to scheduled transaction plan language and may warrant examination of his contemporaneous financial or strategic reasoning.

SVP General Counsel Kampani Arjun sold 28,615 shares at avg $40.65 (Nov 24), stock down 34% in 30 days to $42.60 current

Kampani Arjun executed 3 separate sales totaling 28,615 shares for $1,163,248.37 at blended average price $40.65 on 2025-11-24, reducing holdings by 5.8% to 461,014 shares post-transaction. The stock has declined 34.0% over the past 30 days and 7.9% over 90 days to a current price of $42.60, now 38.5% below its 52-week high of $69.27. His prior 5 trades at RKLB (all sells in September 2025) showed consistently positive 30-day returns (29.8% to 40.5%), but with no 90-day outcomes yet measurable. His cross-ticker track record shows 8 prior sells with a 100.00% well-timed rate at the 90-day mark, though the latest sale's timing relative to the company's unprofitable status (net income of $-18.3M on $155.1M quarterly revenue) remains to be determined over the medium term.

SVP General Counsel Kampani Arjun sold 40,601 shares at blended avg $48.67 for $1,976,247.37 across 7 transactions on 2025-09-16/17

Kampani Arjun, SVP General Counsel, executed 7 separate sales totaling 40,601 shares for $1,976,247.37 over two trading days, reducing his position by 7.7% to 489,629 shares held post-transaction. The sales occurred at prices ranging from $47.18 to $51.63, with a blended average of $48.67, near current market levels ($47.18). Notably, his prior sale at RKLB on 2025-11-25 exhibited negative 90-day returns, and his cross-ticker track record shows 1 prior sell with a 100% well-timed rate at the 90-day mark. RKLB is growing revenues rapidly (78.3% annual growth) but remains unprofitable with a $-66.4M net loss in the latest quarter, a material context for executive liquidity activity in a $22.6B market-cap company.

General Counsel Kampani Arjun sold 28,562 shares of RKLB at $24.15; holds 608,996 post-sale amid stock surge to $25.67.

Kampani Arjun, General Counsel of Rocket Lab USA, sold 28,562 shares at $24.15 on 2024-11-25, reducing his holdings by 4.5% to 608,996 shares while retaining a substantial position. The stock has appreciated $1.52 from the sale price to its current $25.67 level, and the company's shares have surged 128.0% over the past 30 days and 312.0% over 90 days from lows of $3.53. Despite strong revenue growth of 15.9% year-over-year and a $12.8B market cap, Rocket Lab remains unprofitable with a net loss of $51,939,000 on quarterly revenue of $104,808,000. The sale occurred during a period of significant momentum but does not appear to reflect a complete exit given the insider's retention of a 609.0K share position.